tiprankstipranks
Trending News
More News >

Chris Howerton Profile - Jefferies Analyst

53 Followers
tipranks
Chris Howerton

Chris Howerton
Jefferies

Wall Street Analyst
#5,205 out of 12,135 Wall Street Analysts
#12,962 out of 44,390 experts

Success Rate

41%
89 out of 219 ratings made a profit

Average Return

+2.10%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Chris Howerton's trades since 2015 and holding each position for 1 Year would result in 40.64% of your transactions generating a profit, with an average return of 2.1% per rating.

Stock Rating Distribution

324Ratings
75.93% Buy
20.37% Hold
3.70% Sell
Distribution of Chris Howerton's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
Prometheus Biosciences, Inc
(RXDX)
Rating:Buy
Date:May 17, 2022 - May 17, 2023
Return:+501.90%
The most profitable rating made by Chris Howerton

Chris Howerton's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Affimed
Oct 15, 2015
Hold
Reiterated
$7.00
3Ratings
0.00%
Altamira Therapeutics
Jul 12, 2016
Buy
Reiterated
$8.00
(6917.54% Upside)
4Ratings
0%
-80.18%
LadRx
Jul 29, 2016
Hold
Reiterated
$0.75
(581.82% Upside)
8Ratings
0.00%
Anthera Pharmaceuticals
Aug 24, 2016
Buy
Reiterated
$45.00
5Ratings
0%
-89.13%
Atara Biotherapeutics
Aug 24, 2016
Buy
Reiterated
$25.00
(493.82% Upside)
15Ratings
11%
-24.39%
Decoy Therapeutics
Aug 24, 2016
Buy
Reiterated
$25.00
(3431.07% Upside)
11Ratings
0%
-60.50%
SPPI
Spectrum Pharmaceuticals
Nov 09, 2016
Hold
Reiterated
10Ratings
0.00%
Minerva Neurosciences
Jan 12, 2017
Buy
Reiterated
$17.00
(172.00% Upside)
9Ratings
17%
-27.48%
Synlogic
Apr 30, 2019
Buy
Initiated
$18.00
(2802.76% Upside)
1Ratings
0%
-75.70%
SBBP
Strongbridge Biopharma
Aug 04, 2020
Buy
Reiterated
2Ratings
0%
-29.65%
List of latest recommendations made by Chris Howerton. Click to expand and see Chris Howerton's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Chris Howerton activity FAQ

What is the performance of Chris Howerton's recommendations?
The percentage of profitable recommendations made by Chris Howerton is 41%, and the average return per transaction is 2.10%.
    What stocks does Chris Howerton cover?
    Chris Howerton mostly covers IMMU ,ATRA ,HRMY stocks.
      What was Chris Howerton's most profitable rating?
      Chris Howerton’s most profitable ratings was a buy on RXDX stock on May 17, 2022 - May 17, 2023. The return on the trade was +501.90%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here